Press Releases
May 17, 2023
IN8bio's DeltEx Gamma-Delta T Cells Show Promise in Targeting Ovarian Cancer
May 12, 2023
IN8bio Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 2, 2023
IN8bio Announces New Preclinical Data in Ovarian Cancer to be Presented at ASGCT 26th Annual Meeting
May 1, 2023
IN8bio Appoints Jeremy Graff, Ph.D., to Board of Directors
April 26, 2023
IN8bio Announces Oral Presentation of New INB-200 Phase 1 Data in Glioblastoma (GBM) to be Presented at 2023 ASCO Annual Meeting